Pregnancy & Prenatal Testing

A highly sensitive Beta hCG urine pregnancy test designed to detect pregnancy as early as 10 days after conception with reliable accuracy.

A highly sensitive qualitative blood test that detects beta-hCG to confirm pregnancy as early as 11 days after conception.

A precise quantitative beta-hCG blood test that measures exact hormone levels to monitor pregnancy progression and detect hCG-producing tumors.

​This panel screens the for carrier status of 3 prenatal diseases: Spinal muscular atrophy (SMA), Fragile X, and Cystic Fibrosis.

A comprehensive genetic blood test that determines Fragile X status to identify affected individuals and carriers for informed healthcare and family planning decisions.

This test is used to determine identification of carriers for four Jewish heritage diseases.

This test is used for identification of carrier and affected individuals for the "2281del6ins7" mutation associated with Bloom syndrome in the Ashkenazi Jewish population.

This test identifies carriers and affected individuals for four mutations associated with Caravan disease: E285A, Y231X, 433-2A>G, and A305E.

A comprehensive genetic blood test that screens for 32 common cystic fibrosis mutations to determine carrier or affected status for informed family planning.

This test identifies carriers of and affected individuals with Fanconi anemia, type C for two associated mutations, IVS4+4A>T and 322delG.

This test will detect carriers of Gaucher disease in the Ashkenazi Jewish population. Enzyme testing is the preferred test to detect affected individuals. DNA testing may be used to confirm affected status.

This test identifies four mutations associated with Niemann-Pick diseases, Type A and B.

A comprehensive SMA genetic blood test that determines carrier status and supports prenatal diagnosis for informed family planning.

A specialized blood test that measures Hex A enzyme activity to determine Tay-Sachs disease or carrier status for informed family planning and genetic clarity.

This STD panel tests for 7 viral sexually transmitted diseases, including HIV Type 1 & 2, Herpes Type 1 & 2, Hepatitis A, B and C.

The Bacterial Infection STD Test Panel tests for four STDs, including Chlamydia, Gonorrhea, Syphilis and Trichomoniasis.

A comprehensive screening that checks for the ten most common sexually transmitted infections, giving broad coverage for routine sexual health.

An expanded screening that includes all tests in the ten panel plus three additional high value infections for a complete sexual health assessment.

This urine test panel is used to detect the strains of bacteria that cause Chlamydia and Gonorrhea: Chlamydia trachomatis and Neisseria gonorrhoeae.

This Hepatitis Panel delivers clear answers about hepatitis A, B, and C exposure, helping protect your liver, your health, and those around you.

The HIV RNA test is used for early detection of HIV. Standard HIV tests measure the levels of the antibodies that fight HIV, whereas RNA-based tests detect the virus itself in the blood.

HIV 4th Generation DUO Tests detect HIV antibodies and P24 antigens, while 3rd generation tests detect only HIV antibodies.